COMMUNIQUÉS West-GlobeNewswire

Galectin Therapeutics Provides Corporate Update at Annual Meeting
14/12/2017
Dr. Peter Traber, CEO and CMO, reviews results of NASH-CX trial that demonstrated statistically significant and clinically meaningful effects in patients who had NASH cirrhosis but did not have esophageal varices [...]
Rockwell Medical Signs Exclusive License Agreement with Comercializadora BioRenal SpA to Commercialize Triferic® in Chile
14/12/2017
- Estimated Market Launch 2 nd -half 2018 Provides Access to 20,000 Dialysis Patients - WIXOM, Mich., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI ), announced today that it has signed an [...]
Mayo Clinic to begin Prospective Clinical Study with Medibio Technology for Expanded Market Opportunities
14/12/2017
Study designed to determine differential diagnosis in depression patients Study designed to monitor patient data following pharmacological treatment SYDNEY, Australia and MINNEAPOLIS, Dec. 14, 2017 (GLOBE NEWSWIRE) -- [...]
Cellectar Files IND for Phase 1 Trial of CLR 131 in Pediatric Cancers
14/12/2017
MADISON, Wis., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]
Catalyst Biosciences Announces Appointment of Edward Williams to its Board of Directors
14/12/2017
Former Novo Nordisk Executive Strengthens Catalyst’s Hemophilia Expertise SOUTH SAN FRANCISCO, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq: CBIO ), a clinical-stage biopharmaceutical [...]
Agritek Holdings, Inc. Announces Deal with Institutional Investor To Eliminate Existing Toxic Convertible Debt Of Approximately $700,000 And Provide Favorable Capital Infusion
14/12/2017
LOS ANGELES, CA, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]
BeyondSpring Meets Primary Objective in Phase 2 Portion of Phase 2/3 Trial (Study 105) with Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia (CIN)
14/12/2017
NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced [...]
PositiveID’s ExcitePCR Named Major Player in Molecular Diagnostics Industry Report
14/12/2017
DELRAY BEACH, Fla., Dec. 14, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its ExcitePCR Corporation [...]
India Globalization Capital Provides Update on Hyalolex for Alzheimer’s Commercialization Strategy
14/12/2017
BETHESDA, Md., Dec. 14, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) today provides an update on corporate initiatives to launch its lead product for Alzheimer’s, Hyalolex, through [...]
Pain Therapeutics Announces New Publication on Alzheimer’s Disease
14/12/2017
AUSTIN, Texas, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ), a biopharmaceutical company, today announced a new publication for PTI-125, a clinical-stage drug candidate with a novel [...]
Golden Leaf Holdings Opens New Chalice Farms Dispensary in Downtown Portland, Oregon
14/12/2017
PORTLAND, Ore., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]
Precipio Files a Patent Application for IV-Cell, its Novel Cytogenetics Media
14/12/2017
NEW HAVEN, Conn., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), today announced the recent filing of a patent application for IV-Cell, a novel media (reagent) developed by Precipio and validated in [...]
HempAmericana Secures Necessary Raw Inputs for Q1 CBD Oil Production
14/12/2017
NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (the “Company”) is excited to confirm that it has secured sufficient necessary raw hemp material for initial production activities to be [...]
Amicus Therapeutics Submits New Drug Application to U.S. FDA for Migalastat for Treatment of Fabry Disease
14/12/2017
CRANBURY, N.J., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) to request approval of the oral precision [...]
Mustang Bio to Participate in LifeSci Advisors Corporate Access Event in San Francisco, January 8 – 10, 2018
14/12/2017
NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) company focused on the development of novel immunotherapies based on proprietary chimeric [...]
Fortress Biotech to Participate in LifeSci Advisors Corporate Access Event in San Francisco, January 8 – 10, 2018
14/12/2017
NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (“Fortress”) (NASDAQ: FBIO ), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]
Strongbridge Biopharma plc Announces New Employment Inducement Awards
14/12/2017
DUBLIN, Ireland and TREVOSE, Pa., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Checkpoint Therapeutics to Participate in LifeSci Advisors Corporate Access Event in San Francisco, January 8 – 10, 2018
14/12/2017
NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a Fortress Biotech (NASDAQ: FBIO ) company, today announced that its senior management team will host [...]
Matinas BioPharma Appoints Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A., to Board of Directors
14/12/2017
BEDMINSTER, N.J., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, [...]

Pages